.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
McKinsey
QuintilesIMS
US Department of Justice
McKesson
Colorcon
Deloitte
Fuji
Daiichi Sankyo
UBS

Generated: June 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065106

« Back to Dashboard
NDA 065106 describes NEOMYCIN AND POLYMYXIN B SULFATE, which is a drug marketed by X Gen Pharms, Watson Labs, Bausch And Lomb, Perrigo Co Tennessee, Akorn, Alcon Pharms Ltd, Ipharm, Amring Pharms, and Sandoz Inc, and is included in twenty-one NDAs. It is available from two suppliers. Additional details are available on the NEOMYCIN AND POLYMYXIN B SULFATE profile page.

The generic ingredient in NEOMYCIN AND POLYMYXIN B SULFATE is bacitracin zinc; hydrocortisone; neomycin sulfate; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the bacitracin zinc; hydrocortisone; neomycin sulfate; polymyxin b sulfate profile page.

Summary for NDA: 065106

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 065106

Suppliers and Packaging for NDA: 065106

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NEOMYCIN AND POLYMYXIN B SULFATE
neomycin sulfate; polymyxin b sulfate
SOLUTION;IRRIGATION 065106 ANDA X-GEN Pharmaceuticals, Inc. 39822-1201 39822-1201-2 10 AMPULE in 1 CARTON (39822-1201-2) > 1 mL in 1 AMPULE (39822-1201-1)
NEOMYCIN AND POLYMYXIN B SULFATE
neomycin sulfate; polymyxin b sulfate
SOLUTION;IRRIGATION 065106 ANDA X-GEN Pharmaceuticals, Inc. 39822-1201 39822-1201-5 50 AMPULE in 1 CARTON (39822-1201-5) > 1 mL in 1 AMPULE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;IRRIGATIONStrengthEQ 40MG BASE/ML;200,000 UNITS/ML
Approval Date:Jan 31, 2006TE:ATRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Cerilliant
Cantor Fitzgerald
Dow
Fuji
US Department of Justice
McKesson
Deloitte
QuintilesIMS
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot